Host genetic susceptibility to severe dengue infection

Tropical Medicine and Health

Volumn 39, Issue 4 SUPPL., 2011, Pages 73-81

  Lan, Nguyen Thi Phuong ^a   Hirayama, Kenji ^b  

^a PASTEUR INSTITUTE   (Viet Nam)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Dengue fever; Dengue hemorrhagic fever; Dengue shock syndrome; Genetic susceptibility; HLA

Indexed keywords

CD209 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

DENDRITIC CELL; DENGUE; DISEASE SEVERITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; IMMUNOREGULATION; NONHUMAN; PATIENT SAFETY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863814141     PISSN: 13488945     EISSN: 13494147     Source Type: Journal    
DOI: 10.2149/tmh.2011-S08     Document Type: Review

References (55)

1. Vannberg FO, Chapman SJ, Hill AV. Human genetic susceptibility to intracellular pathogens. Immunol Rev 2011, Mar; 240(1): 105-116.
2. Eleftherohorinou H, Wright V, Hoggart C, Hartikainen AL, Jarvelin M-R, et al. Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases. PLoS ONE 2009; 4(11): e8068. doi:10.1371/journal.pone.0008068.
3. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 2007, Sep; 30(5-6): 329-340.
4. Ooi EE, Gubler DJ. Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention. Cad Saude Publica 2009; 25 Suppl 1: S115-S124.
5. WHO. Dengue guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 2009.
6. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181: 2-9.
7. Lan NT, Kikuchi M, Vu TQ, Do QH, Tran TT, Vo DT, Ha MT, Vo VT, Cao TP, Tran VD, Oyama T, Morita K, Yasunami M, Hirayama K. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2008, Oct 1; 2(10): e304.
8. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM, da Rosa AT. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997; 230: 244-251.
9. Long HT, Hibberd ML, Hien TT, Dung NM, Van Ngoc T, Farrar J, Wills B, Simmons CP. Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. J Infect Dis 2009, Feb 15; 199(4): 537-546.
10. Halstead SB. Dengue. 1st ed. London: Imperial College Press; 2008.
11. Gagnon SJ, Mori M, Kurane I, Green S, Vaughan DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL. Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol 2002; 67: 41-46.
12. Green S, Rothman A. Immunopathogic mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Inf Dis 2006; 19: 429-436.
13. King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 2000, Aug; 74(15): 7146-7150.
14. EBI/EMBL. (2008) IMGT/HLA Database, release 2.20.0. European Bioinformatics Institute/ European Molecular Biology Laboratory. Available at www.ebi.ac.uk/imgt/hla
15. Chaturvedi UC, Agarwal R, Elbishbish EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Mic 2000; 28: 183-188.
16. Stephens HA. HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 2010; 338: 99-114.
17. Wagenaar JFP, Mairuhu ATA, van Gorp ECM. Genetic influences on dengue virus infections. Dengue Bulletin 2004; 28: 126-134.
18. Fink J, Gu F, Vasudevan SG. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol 2006; 16: 263-275.
19. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HAF, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 2002; 168: 5959-5965.
20. King NJ, Shrestha B, Kesson AM. Immune modulation by flaviviruses. Adv Virus Res 2003; 60: 121-155.
21. Kalayanarooj S, Gibbons RV, Vaughan D, Green S, Nisalak A, Jarman RG, Mammen MP, Perng GC. Blood group AB is associated with increased risk for severe dengue disease in secondary infections. J Infect Dis 2007; 195: 1014-1017.
22. García G, Sierra B, Pérez AB, Aguirre E, Rosado I, Gonzalez N, Izquierdo A, Pupo M, Danay Díaz DR, Sánchez L, Marcheco B, Hirayama K, Guzmán MG. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. Am J Trop Med Hyg 2010, Jun; 82(6): 1153-1156.
23. Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, Alvarez M, Sanchez L, Valdes L, Volk HD, Guzman MG. Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol 2010, Nov; 71(11): 1135-1140.
24. Silva LK, Blanton RE, Parrado AR, Melo PS, Morato VG, Reis EA, Dias JP, Castro JM, Vasconcelos PF, Goddard KA, Barreto ML, Reis MG, Teixeira MG. Dengue hemorrhagic fever is associated with polymorphisms in JAK1. Eur J Hum Genet 2010, Nov; 18(11): 1221-1227. Epub 2010 Jun 30.
25. Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S, Kalayanarooj S, Endy TP, Libraty DH, Nisalak A, Innis BL, Rothman AL, Ennis FA, Chandanayingyong D. HLA-A and-B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002; 60: 309-318.
26. La Fleur C, Granados J, Vargas-Alarcon G, Ruíz-Morales J, Higuera L, Hernandez-Pacheo G, Cutino-Moguel T, Rangel H, Figuera R, Acosta M, Lazcano E, Ramos C. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol 2002; 63: 1039-1044.
27. Sierra B, Alegre R, Perez AB, Garcia G, Sturn-Ramirez K, Obansanjo O, Aguirre E, Alvarez M, Rodriguez-Roche R, Valdes L, Kanki P, Guzman MG. HLA-A,-B,-C, and-DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 2007; 68: 531-540.
28. Goldsby RA, Kindt TK, Osborne BA, Kuby J. Immunology. 5th Edition. New York: W.H. Freeman and Company; 2003.
29. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr., Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S. Gene map of the extended human MHC. Nature Rev Immunol 2004; 5: 889-899.
30. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA. Early immune activation in acute dengue is related to development of plasma leakage and disease severity. J Infect Dis 1999; 179: 755-762.
31. Fernández-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 2004, Oct; 64(4): 469-472.
32. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV. Strong HLA class Ierestricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 2001; 184: 1369-1373.
33. Vejbaesya S, Luangtrakool P, Luangtrakool K, Kalayanarooj S, Vaughn DW, Endy TP, Mammen MP, Green S, Libraty DH, Ennis FA, Rothman AL, Stephens HA. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 2009; 199 (10): 1442-1448.
34. Minhas K, Micheal S, Ahmed F, Ahmed A. Strong association between the-308 TNF promoter polymorphism and allergic rhinitis in pakistani patients. J Investig Allergol Clin Immunol 2010; 20(7): 563-566.
35. Falcón-Lezama JA, Ramos C, Zuñiga J, Juárez-Palma L, Rangel-Flores H, García-Trejo AR, Acunha-Alonzo V, Granados J, Vargas-Alarcón G. HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever. Acta Trop 2009, Nov; 112(2): 193-197. Epub 2009 Aug 3.
36. Chiewsilp P, Scott RM, Bhamarapravati N. Histocompatibility anti-gens and dengue hemorrhagic fever. Am J Trop Med Hyg 1981; 30: 1100-1105.
37. Appanna R, Ponnampalavanar S, Lum Chai See L, Sekaran SD. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS One 2010, Sep 28; 5(9). pii: e13029.
38. Moi ML, Lim CK, Takasaki T, Kurane I. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J Gen Virol 2010, Jan; 91(Pt 1): 103-111.
39. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J, Hill A. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 2002; 67: 102-106.
40. Mukhopadhyaya PN, Acharya A, Chavan Y, Purohit SS, Mutha A. Metagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in an Indian population. Genet Mol Res 2010, Oct 19; 9(4): 2060-2068.
41. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM, Malasit P, Despres P, Julier C. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005; 37: 507-513.
42. Soundravally R, Hoti SL. Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: role of TAP and HPA gene polymorphism. Hum Immunol 2007; 68: 973-979.
43. Rothman AL. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol 2010; 338: 83-98.
44. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008, Dec; 226: 205-218.
45. Simmons CP, Popper S, Dolocek C, Chau TN, Griffiths M, Dung NT, Long TN, Hoang DM, Chau NV, Thao Le TT, Hian TT, Relman DA, Farra J. Patterns of host genomewide transcription abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007; 195: 1097-1107.
46. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000, Jun 15; 405(6788): 827-836.
47. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2001, Apr; 30(3): 229-233.
48. Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, Groen J. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol 2004, Mar; 72(3): 445-450.
49. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM. Correlation of serum levels of macrophage inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 2006; 74: 142-147.
50. Moreno-Altamirano MM, Romano M, Legorreta-Herrera M, Sanchez-Garcia FJ, Colston MJ. Gene expression in human macrophages infected with dengue virus serotype-2. Scand J Immunol 2004; 60: 631-638.
51. Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, Chin KC, Aw P, George J, Kuznetsov VA, Schreiber M, Vasudevan SG, Hibberd ML. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 2007; 1(2): e86.
52. Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. J Infect Dis 2008, May 15; 197(10): 1459-1467.
53. Devignot S, Sapet C, Duong V, Bergon A, Rihet P, Ong S, Lorn PT, Chroeung N, Ngeav S, Tolou HJ, Buchy P, Couissinier-Paris P. Genome-Wide Expression Profiling Deciphers Host Responses Altered during Dengue Shock Syndrome and Reveals the Role of Innate Immunity in Severe Dengue. PLoS One 2010; 5(7): e11671.
54. Tolfvenstam T, Lindblom A, Schreiber MJ, Ling L, Chow A, Ooi EE, Hibberd ML. Characterization of early host responses in adults with dengue disease. BMC Infect Dis 2011, Aug 2; 11(1): 209.
55. Polizel JR, Bueno D, Visentainer JE, Sell AM, Borelli SD, Tsuneto LT, Dalalio MM, Coimbra MT, Moliterno RA. Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population. Mem Inst Oswaldo Cruz 2004 Oct; 99 (6): 559-562.